27 confirmed cases of Mpox, 1 death reported from India since 2022: WHO
New Delhi, Aug 13 (IANS) India reported 27 laboratory-confirmed cases of Mpox (formerly Monkeypox) and one death between January 2022 and June 2024, said the World Health Organization’s (WHO) in its latest update on Tuesday. The WHO’s 35th situation report for the multi-country outbreak of Mpox showed that in June 2024 (the latest complete monthly
New Delhi, Aug 13 (IANS) India reported 27 laboratory-confirmed cases of Mpox (formerly Monkeypox) and one death between January 2022 and June 2024, said the World Health Organization’s (WHO) in its latest update on Tuesday.
The WHO’s 35th situation report for the multi-country outbreak of Mpox showed that in June 2024 (the latest complete monthly disease surveillance data available), a total of 934 new laboratory-confirmed cases of mpox and four deaths were reported from 26 countries.
“This illustrates continuing transmission of Mpox across the world,” the global health body said.
As per the report, with 567 cases the African Region is most affected between January 2022 and June 2024. This is followed by the Americas (175 cases), the European Region (100 cases), the Western Pacific Region (81 cases), and the South-East Asia Region (11 cases). The Eastern Mediterranean region did not report cases in June 2024, the WHO said.
In the South-East Asia region, Thailand reported the highest number of confirmed cases (805) followed by Indonesia (88), India (27), Sri Lanka (4), and Nepal (1). Thailand also reported the highest number of deaths from Mpox (10) in the region, followed by India (1).
“As reporting from countries to WHO has been declining, the current reported global data most likely underestimate the actual number of Mpox cases,” said the WHO, emphasising the importance of surveillance.
The report noted that four new countries in Eastern Africa — Burundi, Kenya, Rwanda, and Uganda — have reported their first Mpox cases.
Clade I is responsible for the rising infections in these countries, the UN health body said.
Separately, Cote d’Ivoire (Ivory Coast) in West Africa is experiencing an outbreak of Mpox linked to clade II MPXV, while South Africa has reported two more confirmed cases, it added.
Mpox is a viral zoonotic disease that occurs primarily in tropical rainforest areas of central and west Africa and is occasionally exported to other regions.
It was first identified in monkeys in research laboratories in the 1950s, and it was not until 1970 that the first human case was discovered.
Meanwhile, WHO chief Tedros Adhanom Ghebreyesus is also expected to soon convene an emergency committee under the International Health Regulations (IHR) to decide “whether the outbreak represents a public health emergency of international concern (PHEIC)”.
PHEIC is the highest health alarm by the WHO. Since 2009, PHEIC has been declared seven times for H1N1 swine flu, poliovirus, Ebola, Zika, Covid-19, and mpox.
–IANS
rvt/
BJD Team Submits Report on Polavaram Project to Naveen Patnaik
Next Article10 Students Injured in Lightning Strike in Bhanjanagar
Related Articles
New AI tool to revolutionise personalised cancer treatment

Health & LifestyleNew AI tool to revolutionise personalised cancer treatment
New Delhi: An international team of scientists has developed an artificial intelligence (AI) tool that could revolutionise cancer treatment by mapping cellular diversity within tumours. The innovation tackles tumour heterogeneity in oncology, where varied cell populations cause treatment resistance and recurrence, Xinhua news agency reported. The AAnet AI tool, developed by the Sydney-based Garvan Institute
Covid-19 virus protein triggers immune attack on healthy cells: Study

Health & LifestyleCovid-19 virus protein triggers immune attack on healthy cells: Study
New Delhi: Amid a fresh wave of Covid-19, Israeli researchers have discovered that a protein from the SARS-CoV-2 virus can cause the immune system to attack healthy cells mistakenly. The study, published in the journal Cell Reports, sheds light on how severe Covid complications may occur and suggests new ways to prevent immune-driven damage from
Global AI collaboration revolutionises personalised cancer treatment

Health & LifestyleGlobal AI collaboration revolutionises personalised cancer treatment
New Delhi: An international team of scientists has unveiled an artificial intelligence (AI) technique that securely analyses global cancer samples, paving the way for more personalised and privacy-protected cancer treatments. This innovative approach promises to accelerate personalised cancer treatment by enabling clinicians to match therapies to individual patients better, Xinhua news agency reported. The study
